PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Go back to PTC Therapeutics Provides a Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 81.05 +2.07 (2.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $78.98 | 52 Week High | $35.40 | |||
| Open | $80.00 | 52 Week Low | $4.03 | |||
| Day High | $81.71 | P/E | 8.62 | |||
| Day Low | $79.51 | EPS | $9.40 | |||
| Volume | 1,887,131 | |||||
